Skip to content

Similar metrics at other companies

Haemonetics logo
HAEUS — Revenue
$247.71M-3.9%
PTC Therapeutics logo
PTCTUS — Revenue
$136.52M+186%
Zimmer Biomet Holdings logo
ZBHUS — Revenue
$1.21B+8.6%
Glaukos logo
GKOSUS — Revenue
$112.34M+49.7%
Lantheus Holdings logo
LNTHUS — Revenue
$354.43M-0.9%
NTS
NTSKUS — Revenue
$88.7M+26.2%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's us — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's US — revenue?
Merit Medical Systems (MMSI) reported US — revenue of $226.52M in Q1 2026.
How has Merit Medical Systems's US — revenue changed year-over-year?
Merit Medical Systems's US — revenue increased by 6.1% year-over-year, from $213.56M to $226.52M.
What is the long-term trend for Merit Medical Systems's US — revenue?
Over 4 years (2021 to 2025), Merit Medical Systems's US — revenue has grown at a 10.6% compound annual growth rate (CAGR), from $608.88M to $909.47M.
What does US — revenue mean?
This metric represents the total net sales generated from customers within the United States geographic region, excluding any collected sales taxes. It serves as a primary indicator of the company's market penetration and demand for its medical devices and procedural products in its largest domestic market. Monitoring this figure helps investors assess the growth trajectory and commercial success of the company's core operations in the U.S.